Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Open this folder and view contentsOpening ceremony
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Close this folderAntimicrobial resistance - new initiatives
View the documentWHO’s global strategy for the containment of antimicrobial resistance
View the documentImplementing a strategy for the containment of antimicrobial resistance: experience in Uganda
View the documentVeterinary issues contributing to antimicrobial resistance
View the documentStatus of regulation of antimicrobials in Cuba
View the documentFighting antibiotic resistance in Sweden
View the documentAntimicrobial use in Chile - the impact of regulatory measures
View the documentRecommendations
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Open this folder and view contentsHomoeopathy
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Fighting antibiotic resistance in Sweden

Dr Björn Beermann, Sweden

The Swedish Strategic Programme for the Rational Use of

Antimicrobial Agents and Surveillance of Resistance (STRAMA) was initiated in 1994 after signals of increasing resistance to several types of antibiotics were detected. STRAMA is a network of one national multidisciplinary expert group and 30 regional groups.

The goals of the national STRAMA group are:

• to stimulate the formation of regional STRAMA groups;

• to educate health professionals and the public about the problem of inappropriate use of antibiotics and bacterial resistance;

• to design strategies to minimize the development and spread of resistance;

• to further develop and support resistance surveillance programmes.


With the support of the national STRAMA group, each county in Sweden has set up its own regional STRAMA group of multidisciplinary experts. The main objectives of the regional groups are:

• to evaluate the use of antibiotics in the area and the pattern of bacterial resistance;

• to educate health care providers to avoid misuse of antibiotics particularly in hospitals;

• to improve diagnostic procedures in infectious diseases;

• to initiate a study on the treatment of respiratory tract infections and antibiotic use in preschool children.


Since 1993, total antibiotic use has been reduced substantially, especially that of macrolides and broad spectrum antibiotics. The reduction in antibiotic consumption has been more evident in Sweden than in the other Nordic countries. Recommendations on the use of macrolides, vancomycin, and fluoroquinolones, and on the treatment of urinary tract infections, chronic bronchitis, and skin and wound infections, have been produced. A folder containing information on respiratory tract infections, antibiotics and resistance has been distributed to all Swedish health care centres. Symposia have been arranged for regional groups. Media interest for the project has further increased the knowledge and understanding of the problem in the general population. Sweden has been involved in several EU projects on antibiotic resistance.

In conclusion, the overall strategy to fight antibiotic resistance is to build networks with local nodes to collect information and monitor the usage of antimicrobials, and to link the findings to resistance and disease surveillance data. Appropriate policies and education should be provided to ensure the rational use of antimicrobials.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014